Kristina Ransom serves as a Principal Engineer at ICU Medical, where she leverages her extensive expertise in product development, verification and validation, and systems engineering to drive innovative solutions in the medical device industry. With a robust background in both mechanical engineering and biological sciences,...
Kristina Ransom serves as a Principal Engineer at ICU Medical, where she leverages her extensive expertise in product development, verification and validation, and systems engineering to drive innovative solutions in the medical device industry. With a robust background in both mechanical engineering and biological sciences, Kristina is adept at navigating the complexities of product life cycles, from initial concept through to end-of-life management. Her role involves not only the research and design of cutting-edge product lines but also the critical sustaining engineering efforts that ensure product reliability and compliance with stringent regulatory standards.
Currently, Kristina is spearheading several key projects that focus on enhancing the performance and safety of infusion systems, a vital area in patient care. Her proficiency in tools such as Unigraphics and NI LabVIEW allows her to conduct rigorous testing and analysis, including NVH (Noise, Vibration, and Harshness) assessments, ensuring that products meet the highest quality benchmarks. As a Shainin Red X Journeyman and Design for Six Sigma Black Belt, she employs advanced methodologies to address and resolve complex engineering challenges, driving continuous improvement and innovation within her team.
Kristina's commitment to excellence is further demonstrated through her meticulous approach to Medical Device Regulation (MDR) preparation, ensuring that all products not only meet but exceed industry standards. Her diverse skill set, which includes basic machining and mechanical desktop applications, positions her as a versatile leader in the R&D landscape, making significant contributions to the advancement of medical technology and ultimately improving patient outcomes.
